谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Turicibacter and Acidaminococcus Predict Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitor.

Kazuyuki Hamada,Junya Isobe,Kouya Hattori,Masahiro Hosonuma,Yuta Baba,Masakazu Murayama,Yoichiro Narikawa,Hitoshi Toyoda,Eiji Funayama,Kohei Tajima,Midori Shida,Yuya Hirasawa,Toshiaki Tsurui,Hirotsugu Ariizumi,Tomoyuki Ishiguro,Risako Suzuki,Ryotaro Ohkuma,Yutaro Kubota,Takehiko Sambe,Mayumi Tsuji,Satoshi Wada,Yuji Kiuchi,Shinichi Kobayashi,Atsuo Kuramasu,Atsushi Horiike,Yun-Gi Kim,Takuya Tsunoda,Kiyoshi Yoshimura

Frontiers in Immunology（2023）

引用 18|浏览20
关键词
clinical efficacy,gut microbiota,immune checkpoint inhibitors,immune-related adverse events,PD-1 inhibitor,Turicibacter,Acidaminococcus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要